Drawing for NO FALLEN HEROES MAVERICK MIND

USPTO serial 98206867

NO FALLEN HEROES MAVERICK MIND

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FLEBBE, KEVIN ROBERT
Law office
TMO LAW OFFICE 110

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NO FALLEN HEROES MAVERICK MIND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory P. Borgognoni

355 Alhambra Circle, Ste 1205Coral Gables, FL 33134United States

Goods and services

ClassDescriptionStatusFirst use
005Capsules made of dendrimer-based polymers sold empty for pharmaceuticals; Capsules sold empty for pharmaceuticals; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplements; Dietary supplements for controlling cholesterol; Dietary supplements for human beings and animals; Dietary supplements for human consumption; Dietary supplements for humans and animals; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for treatment of claustrophobia; Dietary supplements for urinary health; Dietary supplements in the nature of weight loss powders; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary pet supplements in the form of pet treats; Homeopathic anti-inflammatory ointment; Homeopathic supplements; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Protein supplement shakes; Protein supplements; Acai powder dietary supplements; Activated charcoal dietary supplements; Albumin dietary supplements; Alginate dietary supplements; Allergy capsules; Bee pollen for use as a dietary food supplement; Casein dietary supplements; Chlorella dietary supplements; Coenzyme Q10 dietary supplements; Concentrated saline capsules for sinus and nasal irrigation; Decongestant capsules; DHA algae oil dietary supplements; Diet capsules; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Enzyme dietary supplements; Flavonoids for use as a dietary supplement; Flaxseed dietary supplements; Flaxseed oil dietary supplements; Folic acid dietary supplements; Ganoderma lucidum spore powder dietary supplements; Gelatin capsules sold empty for pharmaceuticals; Gelatin capsules, empty, for pharmaceuticals; Ginseng capsules for medical purposes; Glucose dietary supplements; Green coffee bean extracts for use as dietary supplements; Ground flaxseed fiber for use as a dietary supplement; Herbal male enhancement capsules; Ketogenic dietary and nutritional supplements used for weight loss; Ketone ester beverages for use as a dietary supplement; Lecithin dietary supplements; Linseed dietary supplements; Linseed oil dietary supplements; Liquid protein supplements; Lutein dietary supplements; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Natural dietary supplements; Natural dietary supplements for treatment of claustrophobia; Nutraceuticals for use as a dietary supplement; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Pine pollen dietary supplements; Pollen dietary supplements; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Propolis dietary supplements; Protein dietary supplements; Protein dietary supplements formed and packaged as bars; Royal jelly dietary supplements; Soy isoflavone dietary supplements; Soy protein dietary supplements; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Unit dose capsules sold empty for pharmaceutical use; Vegan liquid protein supplements; Vitamins and dietary food supplements for animals; Wheat for use as a dietary supplement; Wheat germ dietary supplements; Wheatgrass for use as a dietary supplement; Whey protein supplements; Yeast dietary supplements; Zinc dietary supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 6, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 6, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 15, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2024ALIEASSIGNED TO LIE—
Jun 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2024DOCKASSIGNED TO EXAMINER—
Dec 19, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance